United States Anticoagulant Drug Market Report 2016

Publisher Name :
Date: 05-Oct-2016
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of Anticoagulant Drug

Revenue, means the sales value of Anticoagulant Drug

This report studies sales (consumption) of Anticoagulant Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer AG

- Pfizer Inc

- Merck

- Sanofi

- Abbott Laboratories

- Johnson & Johnson

- Armetheon Inc

- Microbix Biosystems Inc

- Biovascular Inc

- Baxter International

- Astrazeneca

- Genentech

- Boehringer Ingelheim Gmbh

- Bristol-Myers Squibb CO

- CSL Behring

- ELI LILLY

- Emisphere Technologies

- Sun Pharmaceuticals

- Shire Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Anticoagulant Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Anticoagulant Drug Market Report 2016

Table of Contents
United States Anticoagulant Drug Market Report 2016
1 Anticoagulant Drug Overview
1.1 Product Overview and Scope of Anticoagulant Drug
1.2 Classification of Anticoagulant Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Anticoagulant Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Anticoagulant Drug (2011-2021)
1.4.1 United States Anticoagulant Drug Sales and Growth Rate (2011-2021)
1.4.2 United States Anticoagulant Drug Revenue and Growth Rate (2011-2021)
2 United States Anticoagulant Drug Competition by Manufacturers
2.1 United States Anticoagulant Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Anticoagulant Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Anticoagulant Drug Average Price by Manufactures (2015 and 2016)
2.4 Anticoagulant Drug Market Competitive Situation and Trends
2.4.1 Anticoagulant Drug Market Concentration Rate
2.4.2 Anticoagulant Drug Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Anticoagulant Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Anticoagulant Drug Sales and Market Share by Type (2011-2016)
3.2 United States Anticoagulant Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Anticoagulant Drug Price by Type (2011-2016)
3.4 United States Anticoagulant Drug Sales Growth Rate by Type (2011-2016)
4 United States Anticoagulant Drug Sales (Volume) by Application (2011-2016)
4.1 United States Anticoagulant Drug Sales and Market Share by Application (2011-2016)
4.2 United States Anticoagulant Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Anticoagulant Drug Manufacturers Profiles/Analysis
5.1 Bayer AG
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Anticoagulant Drug Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer AG Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Pfizer Inc
5.2.2 Anticoagulant Drug Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Pfizer Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Merck
5.3.2 Anticoagulant Drug Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Merck Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Sanofi
5.4.2 Anticoagulant Drug Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Sanofi Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Abbott Laboratories
5.5.2 Anticoagulant Drug Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Abbott Laboratories Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Johnson & Johnson
5.6.2 Anticoagulant Drug Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Johnson & Johnson Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Armetheon Inc
5.7.2 Anticoagulant Drug Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Armetheon Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Microbix Biosystems Inc
5.8.2 Anticoagulant Drug Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Microbix Biosystems Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Biovascular Inc
5.9.2 Anticoagulant Drug Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Biovascular Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Baxter International
5.10.2 Anticoagulant Drug Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Baxter International Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Astrazeneca
5.12 Genentech
5.13 Boehringer Ingelheim Gmbh
5.14 Bristol-Myers Squibb CO
5.15 CSL Behring
5.16 ELI LILLY
5.17 Emisphere Technologies
5.18 Sun Pharmaceuticals
5.19 Shire Pharmaceuticals
6 Anticoagulant Drug Manufacturing Cost Analysis
6.1 Anticoagulant Drug Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Anticoagulant Drug
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Anticoagulant Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Anticoagulant Drug Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Anticoagulant Drug Market Forecast (2016-2021)
10.1 United States Anticoagulant Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Anticoagulant Drug Sales Forecast by Type (2016-2021)
10.3 United States Anticoagulant Drug Sales Forecast by Application (2016-2021)
10.4 Anticoagulant Drug Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Anticoagulant Drug
Table Classification of Anticoagulant Drug
Figure United States Sales Market Share of Anticoagulant Drug by Type in 2015
Table Application of Anticoagulant Drug
Figure United States Sales Market Share of Anticoagulant Drug by Application in 2015
Figure United States Anticoagulant Drug Sales and Growth Rate (2011-2021)
Figure United States Anticoagulant Drug Revenue and Growth Rate (2011-2021)
Table United States Anticoagulant Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Anticoagulant Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anticoagulant Drug Sales Share by Manufacturers
Figure 2016 Anticoagulant Drug Sales Share by Manufacturers
Table United States Anticoagulant Drug Revenue by Manufacturers (2015 and 2016)
Table United States Anticoagulant Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Anticoagulant Drug Revenue Share by Manufacturers
Table 2016 United States Anticoagulant Drug Revenue Share by Manufacturers
Table United States Market Anticoagulant Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Anticoagulant Drug Average Price of Key Manufacturers in 2015
Figure Anticoagulant Drug Market Share of Top 3 Manufacturers
Figure Anticoagulant Drug Market Share of Top 5 Manufacturers
Table United States Anticoagulant Drug Sales by Type (2011-2016)
Table United States Anticoagulant Drug Sales Share by Type (2011-2016)
Figure United States Anticoagulant Drug Sales Market Share by Type in 2015
Table United States Anticoagulant Drug Revenue and Market Share by Type (2011-2016)
Table United States Anticoagulant Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anticoagulant Drug by Type (2011-2016)
Table United States Anticoagulant Drug Price by Type (2011-2016)
Figure United States Anticoagulant Drug Sales Growth Rate by Type (2011-2016)
Table United States Anticoagulant Drug Sales by Application (2011-2016)
Table United States Anticoagulant Drug Sales Market Share by Application (2011-2016)
Figure United States Anticoagulant Drug Sales Market Share by Application in 2015
Table United States Anticoagulant Drug Sales Growth Rate by Application (2011-2016)
Figure United States Anticoagulant Drug Sales Growth Rate by Application (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Anticoagulant Drug Sales Market Share (2011-2016)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc Anticoagulant Drug Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Anticoagulant Drug Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Anticoagulant Drug Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Anticoagulant Drug Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Anticoagulant Drug Sales Market Share (2011-2016)
Table Armetheon Inc Basic Information List
Table Armetheon Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Armetheon Inc Anticoagulant Drug Sales Market Share (2011-2016)
Table Microbix Biosystems Inc Basic Information List
Table Microbix Biosystems Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Microbix Biosystems Inc Anticoagulant Drug Sales Market Share (2011-2016)
Table Biovascular Inc Basic Information List
Table Biovascular Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biovascular Inc Anticoagulant Drug Sales Market Share (2011-2016)
Table Baxter International Basic Information List
Table Baxter International Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter International Anticoagulant Drug Sales Market Share (2011-2016)
Table Astrazeneca Basic Information List
Table Astrazeneca Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astrazeneca Anticoagulant Drug Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Anticoagulant Drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim Gmbh Basic Information List
Table Boehringer Ingelheim Gmbh Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Gmbh Anticoagulant Drug Sales Market Share (2011-2016)
Table Bristol-Myers Squibb CO Basic Information List
Table Bristol-Myers Squibb CO Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb CO Anticoagulant Drug Sales Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Behring Anticoagulant Drug Sales Market Share (2011-2016)
Table ELI LILLY Basic Information List
Table ELI LILLY Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table ELI LILLY Anticoagulant Drug Sales Market Share (2011-2016)
Table Emisphere Technologies Basic Information List
Table Emisphere Technologies Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Emisphere Technologies Anticoagulant Drug Sales Market Share (2011-2016)
Table Sun Pharmaceuticals Basic Information List
Table Sun Pharmaceuticals Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceuticals Anticoagulant Drug Sales Market Share (2011-2016)
Table Shire Pharmaceuticals Basic Information List
Table Shire Pharmaceuticals Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Pharmaceuticals Anticoagulant Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticoagulant Drug
Figure Manufacturing Process Analysis of Anticoagulant Drug
Figure Anticoagulant Drug Industrial Chain Analysis
Table Raw Materials Sources of Anticoagulant Drug Major Manufacturers in 2015
Table Major Buyers of Anticoagulant Drug
Table Distributors/Traders List
Figure United States Anticoagulant Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Anticoagulant Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Anticoagulant Drug Production Forecast by Type (2016-2021)
Table United States Anticoagulant Drug Consumption Forecast by Application (2016-2021)
  • Global Bacillus Subtilis Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 24-Mar-2017        Price: US 3480 Onwards        Pages: 117
    Bacillus subtilis, known also as the hay bacillus or grass bacillus, is a Gram-positive, catalase-positive bacterium, found in soil and the gastrointestinal tract of ruminants and humans. A member of the genus Bacillus, B. subtilis is rod-shaped, and can form a tough, protective endospore, allowing it to tolerate extreme environmental conditions. B. subtilis has historically been classified as an obligate aerobe, though evidence exists that it is a facultative aerobe. B. subtilis is considered t......
  • Asia-Pacific Plasminogen Activator Inhibitor Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Plasminogen Activator Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Plasminogen Activator Inhibitor for these regions, from 2012 to 2022 (forecast), including - China - Japan......
  • Asia-Pacific Natriuretic Peptide Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the Asia-Pacific Natriuretic Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Natriuretic Peptide for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea -......
  • Asia-Pacific Demineralized Bone Matrix Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the Asia-Pacific Demineralized Bone Matrix market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Demineralized Bone Matrix for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Ko......
  • Asia-Pacific Creatine Kinase Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the Asia-Pacific Creatine Kinase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Creatine Kinase for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Asia-Pacific Cardiac Troponin Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the Asia-Pacific Cardiac Troponin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Cardiac Troponin for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwa......
  • Asia-Pacific Argatroban Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the Asia-Pacific Argatroban market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Argatroban for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan - I......
  • EMEA (Europe, Middle East and Africa) Herbal Oil Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the EMEA Herbal Oil market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Herbal Oil for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East......
  • United States Veterinary Pain Management Drugs Market Report 2017
    Published: 23-Mar-2017        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Veterinary Pain Management Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs